The global biomaterial market size attained a value of USD 130.8 billion in 2022. The market is likely to grow further at a CAGR of 14.10% during the forecast period of 2023-2031 to attain a value of USD 429.9 billion by 2031.
Some common uses of biomaterials include the creation of artificial organs, joint replacements, stents, dental implants, and wound healing products. Additionally, they are employed in the controlled release of drugs, providing targeted and sustained delivery of therapeutic agents. Overall, biomaterials have revolutionized healthcare, enhancing patient outcomes, and improving overall quality of life.
Moreover, ongoing research and development efforts are leading to the emergence of novel biomaterials with enhanced biocompatibility and functionality. As a result, the biomaterials market is expected to continue expanding at a robust pace, presenting lucrative opportunities for both established players and new entrants in the field.
Biomaterial Market: Introduction
Biomaterials are natural or synthetic materials designed to interact with biological systems for various therapeutic or diagnostic purposes. They play a crucial role in diverse fields such as tissue engineering, regenerative medicine, drug delivery, and medical devices. These materials have unique properties that allow them to mimic the natural environment of cells and tissues, ensuring biocompatibility and safety for use in the human body.Some common uses of biomaterials include the creation of artificial organs, joint replacements, stents, dental implants, and wound healing products. Additionally, they are employed in the controlled release of drugs, providing targeted and sustained delivery of therapeutic agents. Overall, biomaterials have revolutionized healthcare, enhancing patient outcomes, and improving overall quality of life.
Biomaterial Market Segmentations
The market can be categorised into product, application, and major region.Market Breakup by Product
- Natural Biomaterial
- Metallic Biomaterial
- Ceramic Biomaterial
- Polymeric Biomaterial
Market Breakup by Application
- Neurology
- Neural stem cell encapsulation
- Shunting systems
- Hydrogel scaffold
- Cortical neural prosthetics
- Others
- Cardiology
- Sensors
- Stents
- Implantable Cardiac defibrillators
- Pacemakers
- Vascular graft Market
- Others
- Orthopaedics
- Joint Replacement Biomaterials
- Orthobiologics
- Bio-resorbable tissue fixation products
- Viscosupplementation
- Spine Biomaterials
- Others
- Ophthalmology
- Synthetic Corneas
- Intraocular Lens Market
- Contact Lens
- Ocular tissue replacement
- Others
- Wound Care
- Fracture Healing Device
- Adhesion Barrier
- Skin Substitute
- Internal Tissue Sealant
- Surgical Haemostats
- Others
- Dental
- Tissue Regeneration Material
- Dental Implants
- Bone Grafts and Substitutes
- Dental Membranes
- Others
- Plastic Surgery
- Facial Wrinkle Treatment
- Soft Tissue Fillers
- Craniofacial Surgery
- Bioengineered skins
- Peripheral nerve repair
- Acellular dermal matrices
- Others
- Others
Biomaterial Market Breakup by Region
North America
- United States of America
- Canada
Europe
- United Kingdom
- Germany
- France
- Italy
- Others
Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
Latin America
- Brazil
- Argentina
- Mexico
- Others
Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Biomaterial Market Scenario
The biomaterials market has witnessed significant growth in recent years, driven by advancements in material science, increasing demand for medical implants, and a growing aging population with a heightened need for healthcare solutions. This global market encompasses a wide range of materials, including metals, ceramics, polymers, and natural materials, catering to diverse applications in orthopaedics, cardiovascular, dental, ophthalmology, and wound care, among others.Moreover, ongoing research and development efforts are leading to the emergence of novel biomaterials with enhanced biocompatibility and functionality. As a result, the biomaterials market is expected to continue expanding at a robust pace, presenting lucrative opportunities for both established players and new entrants in the field.
Key Players in the Global Biomaterial Market
The report gives an in-depth analysis of the key players involved in the biomaterial market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:- Koninklijke DSM N.V
- Corbion N.V
- Zimmer Biomet
- Noble Biomaterials Inc
- Bayer AG
- Berkeley Advanced Biomaterials
- Evonik Industries AG
- CAM Bioceramics B.V
- Grifols, S.A
- Invibio Ltd
- BASF SE
- Zimmer Biomet Holdings, Inc
- Pfizer Inc, Alkermes
- Covalon Technologies Ltd
- Collagen Matrix, Inc
- Corbion
Table of Contents
1 Preface
3 Global Biomaterial Market Overview
4 Global Biomaterial Market Landscape
5 Global Biomaterial Market Dynamics
6 Global Biomaterial Market Segmentation
7 North America Biomaterial Market
8 Europe Biomaterial Market
9 Asia Pacific Biomaterial Market
10 Latin America Biomaterial Market
11 Middle East and Africa Biomaterial Market
12 Patent Analysis
13 Grants Analysis
14 Funding Analysis
15 Partnership and Collaborations Analysis
16 Regulatory Framework
17 Supplier Landscape
18 Global Biomaterial Market- Distribution Model (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
21 Payment Methods (Additional Insight)
Companies Mentioned
- Koninklijke Dsm N.V.
- Corbion N.V.
- Zimmer Biomet
- Noble Biomaterials Inc.
- Bayer AG
- Berkeley Advanced Biomaterials
- Evonik Industries AG
- Cam Bioceramics B.V.
- Carpenter Technology Corporation
- Grifols, S.A.
- Invibio Ltd.
- Basf Se
- Zimmer Biomet Holdings, Inc.
- Pfizer Inc, Alkermes
- Covalon Technologies Ltd.
- Collagen Matrix, Inc.
- Corbion
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 147 |
| Published | April 2023 |
| Forecast Period | 2023 - 2031 |
| Estimated Market Value ( USD | $ 149.2 Billion |
| Forecasted Market Value ( USD | $ 429.9 Billion |
| Compound Annual Growth Rate | 14.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 17 |
